Rano Nalibaeva

5 та иш

Republican Specialized Scientific and Practical Medical Center of Phthisiology and Pulmonology, Tashkent, Uzbekistan

1. Community-acquired pneumonia: risk and prognosis

   Rano Nalibaeva, Irina Liverko

   МақолаHealthcare Systems and Public Health20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.011325

2. Frequency of occurrence and gene-serotype characteristic of streptococcus pneumoniae in cohort of patients with COPD

   Rano Nalibaeva, Irina Liverko

   МақолаPneumonia and Respiratory Infections20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.011411

3. Both Phage and vaccine Prevenar-13 prevent patients with COPD form community acquired pneumonia

   Rano Nalibaeva, Irina Liverko

   МақолаPneumonia and Respiratory Infections20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.008689

4. Streptococcal bacteriophage and Prevenar-13 vaccine are comparably effective in Pneumococcal pneumonia in patients with COPD

   Rano Nalibaeva, Irina Liverko

   МақолаPneumonia and Respiratory Infections20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.010591

5. Characterization of Diagnosed Streptococcus pneumoniae Serotypes in COPD Patients

   Rano Nalibaeva, Irina Liverko

   МақолаPneumonia and Respiratory Infections20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.010592